TCRX
TScan Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseOct 22, 2026 3:51:08 PM EDT
0.22USD-3.036%(-0.01)299,115
TCRX Financials
In Q2 FY 2026 (ended ), TScan Therapeutics, Inc. Common Stock (TCRX) reported revenue of $1.05M, net income of −$30.36M, operating cash flow of −$27.54M, and assets of $171.45M.
Loading financial statements…